• Image of AMVUTTRA medication Image of AMVUTTRA medication
    • AMVUTTRA

    • QTY 0.5
    • 25MG/0.5ML
    • Syringe
    • Near  77381

VUTRISIRAN (vue TRI sir AN) treats nerve pain, tingling, or numbness in the hands or feet in people with transthyretin amyloidosis (ATTR). It may also be used to lower the risk of worsening disease and death caused by cardiomyopathy. It works by decreasing the buildup of a protein that causes nerve injury and thickening of the heart muscle. This decreases symptoms. It also makes it easier for your heart to pump blood to the rest of your body.


AMVUTTRA Lifestyle Interactions

  • Nitroglycerin 0.4mg/1h, Transdermal Patch - 24 Hour

    Interaction: Alcohol
    Severity: Major
    Notes for Consumers: Do not drink alcohol while taking this medication. Drinking alcohol while taking this medication increases the risk for dangerously low blood pressure. Contact your care team right away if you experience dizziness, feeling faint or lightheaded, or blurry vision.
    Notes for Professionals: Alcohol may increase the frequency of nitroglycerin-related adverse effects including lightheadedness on standing, especially just after rising from a recumbent or seated position. The vasodilating effects of nitroglycerin may also be additive with those of alcohol.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.